Biohaven Pharmaceutical Holding Company Ltd.
USE OF RILUZOLE ORAL DISINTIGRATING TABLETS FOR TREATING DISEASES
Last updated:
Abstract:
Disclosed are methods of treating a disease in a patient in need thereof, comprising administering to the patient a pharmaceutical composition comprising a therapeutically effective amount of riluzole, or a pharmaceutically acceptable salt thereof, in the form of an oral solid molded fast-dispersing dosage form. Pharmaceutical compositions and kits are also disclosed.
Status:
Application
Type:
Utility
Filling date:
26 May 2019
Issue date:
14 Jul 2022